Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab. (Q38621226)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Karl Wassmann

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Alan M Christenfeld

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

David Fisher

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Chrisann Kyi

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

John M Kirkwood

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

William K Oh

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

publication date

15 August 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Journal for Immunotherapy of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

67

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Pembrolizumab versus Ipilimumab in Advanced Melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Blood mRNA expression profiling predicts survival in patients treated with tremelimumab

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS.

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers.

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1186%2FS40425-017-0272-Z

21 January 2018

Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC

1 reference

https://pubmed.ncbi.nlm.nih.gov/28807052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear export of mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/28807052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28807052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S40425-017-0272-Z

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

PubMed publication ID

2 references

Europe PubMed Central

PubMed publication ID

4 September 2017

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28807052%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38621226&oldid=2269127534"